Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schmidt, Marcus; Decker, Thomas; Fehm, Tanja et al.
A phase II study of metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic hormone receptor positive (HR plus ) / human epidermal growth factor receptor 2 negative (HER2-) breast cancer resistant to endocrine therapy - VinoMetroCANCER RESEARCH. Bd. 78. H. 4. 2018
Coombes, R. C.; Tovey, Holly; Kilburn, Lucy et al.
A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT - Randomised EuropeAn celecoxib trial)CANCER RESEARCH. Bd. 78. H. 4. 2018
Mueller, V.; Park-Simon, T. -W.; Huober, J. et al.
A randomized, double-blinded pivotal study of tucatinib (ONT-380) vs. placebo in combination with capecitabine and trastuzumab in patients with pretreated HER2-pos. unresectable locally advanced or metastatic breast cancer: HER2CLIMBONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 28-28
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)CANCER RESEARCH. Bd. 78. H. 4. 2018
Heimes, Anne-S.; Jaekel, J.; Weyer-Elberich, V. et al.
A retrospective analysis of immunohistochemically determined IRF4 expression in a consecutive cohort of 114 ovarian cancer patientsONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 92-92
Thill, Marc; Liedtke, Cornelia; Mueller, Volkmar et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018BREAST CARE. Bd. 13. H. 3. 2018 S. 209-215
Weikel, W
Aspekte der RehabilitationSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
Frees, S; Breuksch, I; Haber, T et al.
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinomaOncotarget. Bd. 16. H. 1. 2018 S. 35
Merzenich, Hiltrud; Blettner, Maria; Niehoff, Dorothea et al.
Cardiac late events in German breast cancer patients: a validation study on the agreement between patient self-reports and information from physiciansBMC CARDIOVASCULAR DISORDERS. Bd. 18. 2018
Thaler, Sonja; Schad, Arno; Kirkpatrick, Charles James et al.
Cellular senescence within HER2-amplified breast cancer: Potential implications for breast cancer immune surveillance and HER2-targeted therapy resistanceCANCER RESEARCH. Bd. 78. H. 4. 2018